Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03344978
Other study ID # UAB Neo 018
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date June 11, 2019
Est. completion date September 27, 2021

Study information

Verified date October 2021
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will determine whether the efficacy of Mylar-lined cardboard cots is equivalent to traditional incubators in their ability to prevent hypothermia (axillary temperature < 36° C) in preterm neonates <36 6/7 weeks gestational age in a randomized cross-over designed trial. Infants will be randomized to receive care in the cardboard cot or incubator and then cross over to the other device for 24 hour periods, rotating for a total of 96 hours total trial time.


Description:

The aim of the trial is to determine whether a corrugated cardboard cot will assist in maintaining infant axillary temperatures comparing it to the temperatures of the same infant being nursed in low heat incubators. The study will be done in the context of standard medical care, including the WHO thermoregulation protocol (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling). The cardboard cot is approximately 24 inches long to accommodate the length of the infant and about 12 inches wide to accommodate term infants, even beyond the first months after birth. The cots are fully lined with a reflective metallized film sheet of Mylar. The cot will be covered with a cardboard piece also lined in reflective film up to about the infant's shoulders so that the infant's face is visible. Attached to the lid is a 5 inch cardboard flap lined with reflective film which folds down into the body of the cot to reduce heat loss. Infants ≤ 36 6/7 weeks gestation will be randomized to receive care in a cardboard cot or an incubator. Infants will begin care in one device and after 24 hours will cross over to the other device for another 24 hours. The process will be repeated once more for a total of 96 hours of study duration. The infants will be normothermic and stable when they are enrolled in the trial. Axillary temperatures will be measured at 1 hr, 6 hours and 24 hours after being placed in the cost or incubator. Infants with observed hypothermia (<36° C) will have measures taken to increase temperature (i.e. adding blankets, hat).


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date September 27, 2021
Est. primary completion date September 27, 2021
Accepts healthy volunteers No
Gender All
Age group N/A to 5 Days
Eligibility Inclusion Criteria: - Estimated gestational age < 36 6/7 weeks - Hospitalized in the NICU at University Teaching Hospital in Zambia - Requiring incubator/radiant warmer for at least 1 week Exclusion Criteria: - Abdominal wall defect or myelomeningocele - Major congenital anomalies - Blistering skin disorder - Suspected Sepsis - Requiring ongoing respiratory support

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cardboard Cot Care
Infant maintained in reflective film-lined cot for a period of 24 hours. Axillary temperatures will be taken at 1 hour, 6 hours, and 24 hours after randomization. If temperatures found < 36° C. at any time, an additional blanket and hat will be added to infant to improve temperature. Infant may be moved to incubator or radiant warmer. All other care will be standard of care at University Teaching Hospital, including warm delivery rooms, immediate drying, postponed bathing and weighing, early and exclusive breastfeeding, and Kangaroo Mother Care as continuously as possible.
Incubator Care
Infant maintained in standard incubator for a period of 24 hours. Axillary temperatures will be taken at 1 hour, 6 hours, and 24 hours after randomization. If temperatures found < 36° C. at any time, an additional blanket and hat will be added to infant to improve temperature. All other care will be standard of care at University Teaching Hospital, including warm delivery rooms, immediate drying, postponed bathing and weighing, early and exclusive breastfeeding, and Kangaroo Mother Care as continuously as possible.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Outcome

Type Measure Description Time frame Safety issue
Primary Moderate (32.-35.9° C) or Severe (<32.0° C) hypothermia per Axillary Temperature Temperature taken via axilla for 1 minute duration 1 hour after placement in warming device
Primary Moderate (32.0-35.9° C) or Severe (<32.0° C) hypothermia per Axillary Temperature Temperature taken via axilla for 1 minute duration 6 hours after placement in warming device
Primary Moderate (32.-35.9° C) or Severe (<32.0°C) hypothermia per Axillary Temperature Temperature taken via axilla for 1 minute duration 24 hours after placement in warming device
Secondary Normothermia (Axillary temperature 36.0 - 38.0° C) Temperature taken via axilla for 1 minute duration 1-96 hours after beginning of study
Secondary Hypothermia (Axillary temperature < 36.0° C) Temperature taken via axilla for 1 minute duration 1-96 hours after beginning of study
Secondary Mean Axillary Temperature in each device Average of all axillary temperatures taken per device 4 months
Secondary Rate of Moderate hypothermia (32.0-35.9° C) after placement in warming device Temperature taken via axilla for 1 minute duration 1 hour after placement in warming device
Secondary Rate of Moderate hypothermia (32.0-35.9°C) after placement in warming device Temperature taken via axilla for 1 minute duration 6 hours after placement in warming device
Secondary Rate of Moderate hypothermia (32.0-35.9° C) after placement in warming device Temperature taken via axilla for 1 minute duration 24 hours after placement in warming device
Secondary Rate of Severe hypothermia (<32.0° C) after placement in warming device Temperature taken via axilla for 1 minute duration 1 hour after placemnt in warming device
Secondary Rate of Severe hypothermia (<32.0° C) after placement in warming device Temperature taken via axilla for 1 minute duration 6 hours after placement in warming device
Secondary Rate of Severe hypothermia (<32.0° C) after placement in warming device Temperature taken via axilla for 1 minute duration 24 hours after placement in warming device
Secondary Rate of Hyperthermia (>38.0°C) after placement in warming device Temperature taken via axilla for 1 minute duration 4 months
See also
  Status Clinical Trial Phase
Completed NCT03146351 - The Effects of Family Centered Intervention Program on Preterm Infants N/A
Completed NCT02064712 - Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates N/A
Completed NCT00365703 - Nasogastric Tube vs. Orogastric Feeding Tube in Preterm Infants: Which is Best? N/A
Terminated NCT00179933 - The Impact of Implementing NIDCAP on Preterm Infants in the NICU N/A
Completed NCT00114543 - Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight Phase 3
Terminated NCT05030012 - Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants N/A
Completed NCT00552383 - The Edmonton Randomised Controlled Trial of NIDCAP - Based Developmental Care N/A
Completed NCT00011362 - Dexamethasone Therapy in VLBW Infants at Risk of CLD Phase 3
Completed NCT06308471 - Effect of Baby Massage on Oral Motor Skills of Premature Babies N/A
Completed NCT01863043 - Aspiration of Residual Gastric Contents N/A
Completed NCT05462509 - Feasibility of Use of the PATH bCPAP and Oxygen Blenders Device With Neonates in Uganda N/A
Not yet recruiting NCT06109350 - The Effect of Physical Therapy Intervention on Motor Performance in Bhutanese Preterm Infants N/A
Terminated NCT02599545 - Testosterone and Cortisol Levels in Infants
Completed NCT03551600 - Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
Completed NCT02611284 - Less Invasive Beractant Administration in Preterm Infants N/A
Completed NCT01193270 - Vitamin E for Extremely Preterm Infants Phase 1
Completed NCT00455169 - Influenza Vaccine in Premature Infants Phase 4
Withdrawn NCT00536445 - Use of NAVA in Intubated Preterm Phase 1/Phase 2
Completed NCT00579553 - Comparing IM vs. Vaginal Progesterone for Pre-term Birth N/A
Completed NCT01203423 - Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study